UPDATE: AVROBIO, Inc. (AVRO) IPO Opens 54% Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
Go back to UPDATE: AVROBIO, Inc. (AVRO) IPO Opens 54% Higher
June 20, 2018 8:42 PM EDT
CAMBRIDGE, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc. (the Company), a Phase 2 clinical stage gene therapy company focused on developing potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose, today announced the pricing of its initial public offering of 5,247,958 shares of common stock at a public offering price of $19.00 per share, before underwriting discounts and commissions, for gross proceeds of $99.7 million. In addition, the Company has granted the underwriters a 30-day option to purchase up to 787,193 additional shares of common stock at the initial public offering price, less underwriting discounts and... More
